edema, left atrial (LA) enlargement, and pulmonary venous distention are notoriously variable in cats with CHF, further complicating the diagnosis. 4, 5 Other diagnostic modalities, such as point-of-care (POC) biomarker testing and ultrasound imaging, are emerging to facilitate a more timely diagnosis and directed treatment of CHF in cats. The POC N-terminal pro-B-type natriuretic peptide (NT-proBNP) test (SNAP Feline proBNP; SNAP Feline proBNP test, IDEXX Laboratories, Inc, Westbrook, Maine) has been helpful in facilitating a rapid and accurate diagnosis of CHF in cats presenting with respiratory distress and pleural effusion (PLEFF). 6, 7 However, noncardiac (NC) diseases, such as severe respiratory or kidney disease, can increase NT-proBNP concentrations and increase the likelihood of false positive results. 8 Point-ofcare lung ultrasound (LUS) and focused cardiac ultrasound (FCU) also have shown promise in accelerating the emergency diagnosis of CHF in cats. 7, [9] [10] [11] Lung ultrasound can suggest a diagnosis of cardiogenic pulmonary edema by demonstrating the presence of ultrasonographic artifacts called B-lines. These B-lines, also called "lung rockets," are linear, hyperechoic, laser-like artifacts that extend from the pleuralpulmonary interface to the far aspect of the ultrasound screen without fading and that move synchronously with respiration. [12] [13] [14] Many studies in humans 12, [15] [16] [17] and a few veterinary studies 9, 10, 13, 18, 19 have
shown that the presence of numerous B-lines in patients presenting with respiratory distress is suggestive of CHF. Conversely, the absence of B-lines strongly refutes the diagnosis of CHF. 11 However, although B-lines are suggestive of CHF, these artifacts also can be present in patients with other causes of fluid accumulation in the alveolarinterstial lung spaces. 12, 15 The finding of LA enlargement on FCU performed by trained clinicians improves the accuracy of CHF diagnosis compared to physical examination alone in cats with respiratory distress. 2, 7 However, obtaining an optimal left atrium-to-aorta ratio (LA : Ao) view can be difficult in animals experiencing respiratory distress, especially cats.
To our knowledge, no study has evaluated the relative diagnostic utility of POC LUS, FCU, and NT-proBNP for diagnosis of CHF in a cohort of cats with respiratory distress. Our primary goal was to compare the diagnostic accuracy of each of these diagnostic tests in predicting a final diagnosis of CHF. Additionally, we sought to determine if any combination of clinical variables or findings on these diagnostic tests yielded optimal diagnostic accuracy. We hypothesized that POC ultrasound findings (LUS and FCU) would have equal or higher diagnostic accuracy compared to POC NT-proBNP alone, and that a combination of all diagnostic tests would offer superior diagnostic accuracy compared with any single test.
| MATERIALS AND METHODS
Procedures were approved by the Institutional Animal Care and Use
Committee at both study sites (North Carolina State University and Iowa State University). Informed owner consent was obtained for each study participant.
Cats presented to the Small Animal Emergency and Critical Care
Services or Cardiology Services at each study site were prospectively enrolled. Inclusion criteria were: (1) cats exhibiting increased respiratory rate (>40 breaths per minute) and increased respiratory effort on physical examination; (2) a trained examiner was available to perform POC ultrasound; and (3) blood was obtained for the POC NTproBNP test within 2 hours of POC ultrasound (either before or after ultrasound).
Cats with PLEFF regardless of severity were included in our study. If thoracocentesis was performed, the NT-proBNP test also was performed on the pleural fluid. Exclusion criteria were: (1) the cat had a respiratory disturbance suspected to be a pain response (ie, obvious nonrespiratory and noncardiac cause of an abnormal breathing pattern); or (2) the cat had a recent history of trauma. Empirical treatment with furosemide before POC ultrasound was not an exclusion criterion.
Cats were stabilized with oxygen, sedation and other therapeutic maneuvers at the discretion of the emergency or cardiology clinician.
Participating POC ultrasound examiners were cardiology and emergency clinicians who had completed a 4-hours training session with an experienced lung ultrasonographer and echocardiographer (T.C. The LUS examinations were performed on all cats using the previously described Vet BLUE protocol for LUS. 14 A Nd sign was defined as a small, well-marginated hypoechoic circular or ellipsoid structure, with or without a hyperechoic distal border, and with or without acoustic enhancement appearing as a B-line extending from its distal border through the far field of the ultrasound screen. 14, [22] [23] [24] A Sh sign was an irregular discontinuity of the expected linear pulmonary-pleural interface with hyperechoic foci within the consolidation, representing lung consolidation with aeration analogous to a radiographic air bronchogram. 14, 22, 23 A Ti sign appeared as linear to triangular discontinuity or deviation from the expected pulmonarypleural interface, void of hyperechoic foci within the consolidation, representing consolidation without aeration described as hepatization of lung. 14, 22, 23, 25 Combinations of PLEFF, B-lines, and sub-pleural abnormalities could be noted within a single Vet BLUE site (eg, a site could contain both PLEFF and B-lines, or a combination of Sh sign and B-lines).
In sites where B-lines were present, the maximum number of B-lines within an intercostal space was recorded as 0, 1, 2, 3, >3 or infinite. 9 Infinite refers to the situation where B-lines are so numerous that they are no longer discernable as individual B-lines (see Figure 1D ). An 3 | RESULTS
| Study population and clinical findings
Fifty-two cats initially met inclusion criteria for the study, but 1 cat was not enrolled because it was too fractious to permit ultrasound Overall, 33 (65%) cats had a final diagnosis of CHF, whereas 18 (35%) were diagnosed with NC causes of respiratory distress.
Causes of CHF were hypertrophic cardiomyopathy (n = 23), hyperthyroid heart disease (n = 5), unclassified cardiomyopathy (n = 3), restrictive cardiomyopathy (n = 1), and unspecified cardiomyopathy (n = 1). 27 Five cats with CHF (5/33, 15%) had recently received IV fluid treatment, and the etiology of CHF in these cases was suspected to include a component of acute fluid overload. The most commonly No significant differences were detected between CHF and NC groups in terms of age, sex, weight, rectal temperature, heart rate, or presence of arrhythmia (see Table 1 ). Overall, 15/51 cats (29%) were diagnosed with a heart murmur on auscultation, including 13/33 (39%) cats diagnosed with CHF and 2/18 (11%) cats diagnosed with NC disease. The difference in murmur incidence between CHF and NC cats was not statistically significant (P = .052). Thirteen cats (25%) had an S4
gallop noted on auscultation, all of which were diagnosed with CHF;
cats with CHF were more likely to have an S4 gallop than cats with NC disease (P = .0017). The only other clinical finding that differed between groups was respiratory rate, with NC cats having higher respiratory rates on presentation compared to cats with CHF (78 +/-30 breaths/minutes versus 63 +/-16 breaths/minutes, P = .024).
| Point-of-care thoracic imaging
Except for the single cat excluded from the study, performance of LUS and FCU was technically feasible (all images obtained at all described sites) in all cats. Lung ultrasound and FCU were completed without difficulty in <5 minutes in 48/51 (94%) cats. In 3 cats, examiners recorded that examination time was prolonged (5-10 minutes)
because of patient instability (n = 2) or behavioral noncompliance (n = 1).
Overall, 44/51 (86%) of cats had at least 1 B-line identified on LUS, including 32/33 (97%) cats with CHF and 12/18 (67%) cats with NC disease (see Table 2 ). Cats with CHF were more likely to have any B-lines compared with cats with NC causes of respiratory distress (P = .0056) A total of 36/51 (71%) cats had PLEFF identified on LUS, including 26/33 (79%) cats with CHF and 10/18 (56%) cats with NC disease (see Table 2 ). Of 8 possible Vet BLUE sites, PLEFF was noted in an average of 2.7 +/-3.2 sites per cat. Incidence of PLEFF (P = .11) and number of sites containing PLEFF (P = .48) did not differ between cats with CHF and NC disease. Nineteen cats (37%)
had at least 1 site that contained both PLEFF and B-lines, with an average of 1.0 +/-1.5 such sites per cat. Coexistence of PLEFF and B-lines was not more common in CHF cats compared with NC cats (P = .37).
Pericardial effusion was noted on FCU in 20/51 cats (39%), all of which were diagnosed with CHF (see Table 2 ). likely to have positive NT-proBNP tests performed on both blood (P < .0001) and PLEFF (P = .034; Table 2 ).
| Biomarker testing

| Diagnostic accuracy
Univariate logistical regression was performed to evaluate clinical, LUS, FCU, and biomarker variables for association with a final diagnosis of CHF. Results for variables found to be significant in univariate analysis are shown in Table 3 . Two variables (subjective LA : Ao enlargement and presence of PCEFF) showed quasi-complete separation on univariate regression, and Chi-square analyses were performed to evaluate their association with CHF diagnosis and obtain Two variables remained significant in the final multivariate regression:
number of strong positive Vet BLUE sites (P = .036) and blood NTproBNP (P = .001). Relative performance of this multivariate model compared with univariate models for the quasi-separated and highly discriminatory univariate variables in univariate analysis are shown in Table 4 . 
| False positive and false negative results
| DISCUSSION
The POC diagnostic techniques (LUS, FCU, and NT-proBNP) used in our study had good to excellent sensitivity and specificity for the diagnosis of CHF in cats with respiratory distress. Regarding LUS, the presence of > 1 Vet BLUE site scoring "strongly positive" for B-lines (>3 B-lines per site) was the criterion with the best diagnostic accuracy. This finding was 78.8% sensitive and 83.3% specific for a diagnosis of CHF. Accuracy of LUS in our study was lower than in a previous study involving 24 cats, in which the Vet BLUE protocol was 87% sensitive and 89% specific for a diagnosis of CHF. 9 This difference likely reflects differences in exclusion criteria between the 2 studies. In the CHF and NC disease. In a previous study, PLEFF was identified as a manifestation of fluid accumulation in 51/100 (51%) cats with acute CHF. 4 The higher incidence of PLEFF in our study might reflect a bias Ninety-five percent confidence intervals for each result are reported in parentheses.
Abbreviations: AUC, area under the receiver operating characteristic curve; LA : Ao, ratio of left atrial to aortic diameter; PCEFF, pericardial effusion; NT-proBNP, N-terminal pro-B-type natriuretic peptide; vet BLUE, veterinary bedside lung ultrasound examination.
in the referred patient population (ie, primary care veterinarians might elect to refer cats with known or suspected PLEFF to a tertiary care center if they lack the equipment or expertise to perform thoracocentesis). The overall frequency of PLEFF in cats with respiratory distress in our study highlights the utility of POC ultrasound to identify PLEFF and expedite therapeutic thoracocentesis.
Pulmonary neoplasia (primary pulmonary or metastatic) was the most common NC cause of false positive LUS results in our study.
This finding differs from previous LUS studies in dogs, in which the most common NC diseases associated with numerous B-lines were acute respiratory distress syndrome, pulmonary thromboembolism, and pneumonia. 9, 28 This difference likely reflects species differences in the types of NC diseases causing respiratory distress. In the studies of dogs, frequently diagnosed underlying diseases included pulmonary thromboembolism, airway disease, and pneumonia. In our study of , it is not surprising that both were highly discriminatory for the diagnosis of CHF. We chose to measure both indices in our study because we wanted to compare the performance of subjective LA : Ao assessment as performed in "real-time" by the POC ultrasound examiner to quantitative LA : Ao measurement of the same image by a cardiologist. Interestingly, the subjective assessment had slightly higher diagnostic accuracy than the objective measurement in our study. However, these 2 variables showed significant overlap in 95% confidence intervals for AUC, and thus this difference could be because of chance (in fact, both indices had such high discriminatory power that neither was entered into the multivariate analysis). Nonetheless, the LA is a complex 3-dimensional dynamic chamber, whereas quantitative LA : Ao is a single 2-dimensional index performed on a static image. It is possible that real-time LA assessment truly does allow superior visualization of the entire LA and left auricle throughout the cardiac cycle, allowing more accurate detection of LA enlargement.
Previous clinical studies similarly have shown that increased LA size in cats with respiratory signs strongly suggests CHF, especially in cats with PLEFF. 2, 7 One study found that a maximal LA size of >16.5 mm measured in B-mode from the right parasternal 4-chamber long axis view had a sensitivity and specificity of 87% for a diagnosis of CHF. 2 In another study, the finding of an enlarged LA during an emergency POC ultrasound increased the confidence and accuracy for the diagnosis of CHF compared with physical examination alone. 7 Our study and previous studies show that conversely, if LA size is normal, NC causes of respiratory distress are more likely.
Ours is the first study to demonstrate that the FCU finding of even a trace amount of PCEFF in a cat with respiratory distress is highly suggestive of CHF. Pericardial effusion was present in 20/33 (61%) cats with CHF in our study and in none of the cats (0/18, 0%) with NC disease. A previous study of cats with acute CHF reported that 23/100 (23%) cats had mild PCEFF on echocardiography. 4 The higher proportion of CHF cats with PCEFF in our study could be explained by differences in ultrasound timing. In the prior study, echocardiography was performed after 43% of cats had received diuretic treatment, 4 whereas only 14% of cats in our study received furosemide before POC ultrasound. Conversely, the largest retrospective case series of cats with PCEFF reported that CHF was the most commonly diagnosed underlying cause of PCEFF, accounting for 113/146 (77%) cases; the remaining 23% of cats were diagnosed with NC diseases including neoplasia or idiopathic PCEFF. 31 In our study, no cat with NC disease had PCEFF. This finding suggests that PCEFF is highly specific for CHF in cats with respiratory distress, but the absence of PCEFF does not rule out CHF. However, the amount of PCEFF can be minimal, and PCEFF might be difficult to distinguish from PLEFF, especially for a novice sonographer.
Point-of-care LUS and FCU had favorable diagnostic utility for evaluating cats with respiratory distress in our study. The main advantage of these POC thoracic ultrasound techniques is that they can be performed quickly (while administering oxygen treatment, if needed) with minimal additional distress to the cat and without the need for clipping hair. For the majority of cats in our study (48/51), both US examinations were completed in <5 minutes with no complications.
Three cats with extreme respiratory distress had more prolonged sensitivity and 86.7% specificity for the diagnosis of CHF. 7 In cats with PLEFF, the POC NT-proBNP test performed on plasma samples also had good to excellent sensitivity (95.2%) and specificity (87.5%) for differentiating CHF from NC causes of effusion. In comparison, when using PLEFF (rather than plasma) as the test sample, the POC test had excellent sensitivity (100%) but low specificity (64.7%). 6 We also evaluated the use of PLEFF samples for POC NT-proBNP testing heart rate, rectal temperature, and presence of a heart murmur, were associated with a final diagnosis of CHF. These findings are somewhat surprising. Given the pathophysiologic nature of heart disease, cats with CHF might be expected to have higher heart rates, lower rectal temperatures, and a higher incidence of heart murmurs compared with cats with NC disease. These findings might be attributable to variable presence of heart murmurs in cats with cardiomyopathy, can lead to substantial differences in image quality. We intentionally chose to use small, portable, moderately priced laptop ultrasound units for our study to most closely approximate the equipment available in a primary care or emergency setting. In-house ultrasound units are becoming more common in veterinary practices, and clinicians will benefit from training and experience in POC techniques such as LUS and FCU.
In our study, the POC diagnostic techniques of LUS, FCU, and NT-proBNP were useful to diagnose CHF in a population of cats with respiratory distress. The presence of subjective LA enlargement, PCEFF, >1 site strongly positive for B-lines, and positive blood NTproBNP all were highly associated with a diagnosis of CHF. Point-ofcare ultrasound is a useful modality in the emergency setting and can provide rapid triage information, particularly for cats in which respiratory distress limits other diagnostic evaluation.
